Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men With Osteoporosis

NCT03512262 is registered in ClinicalTrials.gov with Radius Health, Inc. as lead sponsor.

NCT NCT03512262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03512262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men With Osteoporosis
Lead sponsor
Radius Health, Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 3, 2018
Completion date
September 8, 2021
Enrollment
228 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

age related osteoporosis, osteoporosis, osteoporosis localized to spine, osteoporosis of vertebrae, osteoporosis senile, osteoporosis, age-related